Mission

To develop good practices for outcomes research in the study design and utilization of genomics involved in personalized/precision medicine.

Background

The term "personalized medicine" is often described as providing "the right patient with the right drug at the right dose at the right time. More broadly, personalized medicine (also known as precision medicine) may be thought of as the tailoring of a medical treatment to the individual’s characteristics, needs, and preferences during all stages of care, including prevention, diagnosis, treatment, and follow-up.

Working Groups:


Key Project

Precision Medicine: Assessing the Value

Chair:

  • Fadia T. Shaya, PhD, MPH, Professor, Vice-Chair, Director of Research, University of Maryland School of Pharmacy & Medicine, Baltimore, USA

Work Products

  1. Challenges in the Development and Reimbursement of Personalized Medicine - Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Development and Reimbursement Working Group
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×